# Sirolimus Use in Angioplasty for Vascular Access Extension

> **NCT01595841** · PHASE2 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 17 (actual)

## Conditions studied

- End Stage Renal Disease
- Venous Stenosis

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT01595841
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2022-03
- **Final completion:** 2022-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595841, "Sirolimus Use in Angioplasty for Vascular Access Extension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01595841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*